Through the long-term moderate but significant attenuation of platelet hyperactivity, particularly during the postprandial period, apoA-IV may also slow down the chronic process of atherosclerosis and other inflammatory diseases7,35,51 without impairing hemostasis. The gene discussed is APOA4; the disease is atherosclerosis.